Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II MPThal plus defibrotide in advanced refractory multiple myeloma
2005-003293-25Phase 2Active
- Sponsor
- AOU Città della Salute e della Scienza di Torino
- Start
- Oct 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Vaccine mRNA → mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of melphalan, prednisone, thalidomide and defibrotide in multiple myeloma (MM), sponsored by AOU Città della Salute e della Scienza di Torino. Started Oct 2005; status: active.
02
Drugs
melphalanprednisonethalidomidedefibrotide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2005-003293-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003293-25.